Laimei Pharmaceutical announced that the company plans to sell the land use rights at No. 8 Yueji Road, Nan'an District, Chongqing, and the housing buildings and structures above ground through public listing and transfer. The reserve price for public listing is RMB 31.232 million. If sold at assessed value, the estimated impact on net profit is approximately RMB 208.422 million.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.